Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

Rondy, M; Kissling, E; Emborg, H-; Gherasim, A; Pebody, R; Trebbien, R; Pozo, F; Larrauri, A; McMenamin, J; Valenciano, M; Kaic, B; Filipovic, SK; Visekruna-Vucina, V; Novosel, IP; Lovric, Z; Petrovic, G; Krause, TG; Fische, TK; Lina, B; Falchi, A; Vilcu, A-; Souty, C; Blanchon, T; van der Werf, S; Enouf, V; Behillil, S; Valette, M; Bernard-Stoecklin, S; Levy-Bruhl, D; Launay, O; Loulergue, P; Lenzi, N; Lesieur, Z; L'Honneur, A-; Galtier, F; Agostini, C; Serrand, C; Merle, C; Foulongne, V; Vanhems, P; Laine, F; Lagathu, G; Carrat, F; Buda, S; Preuss, U; Prahm, K; Schweiger, B; Wedde, M; Heider, A; Martin, M; Biere, B; Duerrwald, R; Domegan, L; Coughlan, L; O'Donnell, J; Joyce, M; Collins, C; Dunford, L; Moran, J; Tuite, G; Duffy, M; Connell, J; de Gascun, C; Rizzo, C; Bella, A; Alfonsi, V; Castrucci, MR; Puzelli, S; Pagani, E; Ghisetti, V; Pariani, E; Baldanti, F; Palu, G; D'Agaro, P; Ansaldi, F; Affanni, P; Rossolini, GM; Camilloni, B; Bagnarelli, P; Sanguinetti, M; Atripaldi, L; Chironna, M; Serra, C; Vitale, F; Chironna, M; Germinario, C; Orsi, A; Manini, I; Montomoli, E; Napoli, C; Orsi, GB; Casado, I; Castilla, J; Fernandino, L; Martinez-Baz, I; Ezpeleta, G; Navascues, A; Perez-Garcia, A; Aguinaga, A; Ezpeleta, C; Meijer, A; van den Brink, S; van der Hoek, W; Goderski, G; Wijsman, L; Bagheri, M; Dijkstra, F; de Lange, M; Marzec, T; Overduin, P; Teirlinck, A; Wentink, E; Donker, G; Marbus, S; van Gageldonk-Lafeber, R; Schneeberger, P; van Oosterheert, JJ; Schweitzer, V; Groeneveld, G; Nunes, B; Machado, A; Rodrigues, AP; Gomez, V; Kislaya, I; Guiomar, R; Pechirra, P; Cristovao, P; Costa, I; Panarra, A; Corte-Real, R; Pocas, J; Peres, MJ; Comas, LG; Marisquerena, MEI; Galan, JC; Folgueira, MD; Carril, FG; Martinez, RS; Cilla, G; Castilla, J; Cenoz, MG; Rubio, CQ; Ochoa, EM; Blasco, M; Duran, JG; Vanrell, JM; Reina, J; Castrillejo, D; Gherasim, AM; Delgado, C; Oliva, J; Casas, I; Garcia, M; Latorre, M; Beamonte, AMM; Sapina, AM; Amores, MO; Aizpurua, A; Montes, M; Zakikhany, K; Brytting, M; Wiman, A; Carnahan, A; Warburton, F; Djennad, A; Ellis, J; Andrews, N; Marques, D; Cottrell, S; Reynolds, A; Gunson, R; Galiano, M; Lackenby, A; Robertson, C; O'Doherty, M; Sinnathamby, M; Yonova, I; Moore, C; Sartaj, M; de Lusignan, S; Zambon, M; Moren, A; Penttinen, P

doi:10.2807/1560-7917.ES.2018.23.9.18-00086

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.

Rondy M., Kissling E., Emborg H.-D., Gherasim A., Pebody R., Trebbien R., et al. (2018). Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies. EUROSURVEILLANCE, 23(9) [10.2807/1560-7917.ES.2018.23.9.18-00086].

Data di pubblicazione:	2018
Titolo:	Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies
Autori:	Rondy M. (Corresponding) Kissling E. Emborg H. -D. Gherasim A. Pebody R. Trebbien R. Pozo F. Larrauri A. McMenamin J. Valenciano M. Kaic B. Filipovic S. K. Visekruna-Vucina V. Novosel I. P. Lovric Z. Petrovic G. Krause T. G. Fische T. K. Lina B. Falchi A. Vilcu A. -M. Souty C. Blanchon T. van der Werf S. Enouf V. Behillil S. Valette M. Bernard-Stoecklin S. Levy-Bruhl D. Launay O. Loulergue P. Lenzi N. Lesieur Z. L'Honneur A. -S. Galtier F. Agostini C. Serrand C. Merle C. Foulongne V. Vanhems P. Laine F. Lagathu G. Carrat F. Buda S. Preuss U. Prahm K. Schweiger B. Wedde M. Heider A. Martin M. Biere B. Duerrwald R. Domegan L. Coughlan L. O'Donnell J. Joyce M. Collins C. Dunford L. Moran J. Tuite G. Duffy M. Connell J. de Gascun C. Rizzo C. Bella A. Alfonsi V. Castrucci M. R. Puzelli S. Pagani E. Ghisetti V. Pariani E. Baldanti F. Palu G. D'Agaro P. Ansaldi F. Affanni P. Rossolini G. M. Camilloni B. Bagnarelli P. Sanguinetti M. Atripaldi L. Chironna M. Serra C. VITALE, Francesco Chironna M. Germinario C. Orsi A. Manini I. Montomoli E. Napoli C. Orsi G. B. Casado I. Castilla J. Fernandino L. Martinez-Baz I. Ezpeleta G. Navascues A. Perez-Garcia A. Aguinaga A. Ezpeleta C. Meijer A. van den Brink S. van der Hoek W. Goderski G. Wijsman L. Bagheri M. Dijkstra F. de Lange M. Marzec T. Overduin P. Teirlinck A. Wentink E. Donker G. Marbus S. van Gageldonk-Lafeber R. Schneeberger P. van Oosterheert J. J. Schweitzer V. Groeneveld G. Nunes B. Machado A. Rodrigues A. P. Gomez V. Kislaya I. Guiomar R. Pechirra P. Cristovao P. Costa I. Panarra A. Corte-Real R. Pocas J. Peres M. J. Comas L. G. Marisquerena M. E. I. Galan J. C. Folgueira M. D. Carril F. G. Martinez R. S. Cilla G. Castilla J. Cenoz M. G. Rubio C. Q. Ochoa E. M. Blasco M. Duran J. G. Vanrell J. M. Reina J. Castrillejo D. Gherasim A. M. Delgado C. Oliva J. Casas I. Garcia M. Latorre M. Beamonte A. M. M. Sapina A. M. Amores M. O. Aizpurua A. Montes M. Zakikhany K. Brytting M. Wiman A. Carnahan A. Warburton F. Djennad A. Ellis J. Andrews N. Marques D. Cottrell S. Reynolds A. Gunson R. Galiano M. Lackenby A. Robertson C. O'Doherty M. Sinnathamby M. Yonova I. Moore C. Sartaj M. de Lusignan S. Zambon M. Moren A. Penttinen P. mostra contributor esterni nascondi contributor esterni
Citazione:	Rondy M., Kissling E., Emborg H.-D., Gherasim A., Pebody R., Trebbien R., et al. (2018). Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies. EUROSURVEILLANCE, 23(9) [10.2807/1560-7917.ES.2018.23.9.18-00086].
Rivista:	EUROSURVEILLANCE
Digital Object Identifier (DOI):	http://dx.doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086
Abstract:	Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
Appare nelle tipologie:	1.01 Articolo in rivista

File in questo prodotto:

File	Descrizione	Tipologia	Licenza
eurosurv-23-9-1.pdf		Versione Editoriale		Open Access Visualizza/Apri

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/10447/401670

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

File in questo prodotto: